Capital Bank & Trust’s Chemed CHE Stock Holding History

Capital Bank & Trust’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20	Closed	-$8K	–	730
2019 Q3	$8K	Buy	+20	New	+$8.16K	﹤0.01%	570

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital Bank & Trust's CHE Position: Q4 2019 in Review

Capital Bank & Trust sold out of Chemed (CHE) in Q4 2019, closing a stake of 20 shares — an estimated $8K sold.

Capital Bank & Trust first reported a position in CHE in Q3 2019 and held it in 1 quarter. The position peaked at $8K in Q3 2019. 415 funds tracked by Wall St. Rank hold CHE as of Q4 2019.

Capital Bank & Trust reported no remaining Chemed position as of Q4 2019 after selling out during the quarter.
Capital Bank & Trust sold 20 Chemed shares in Q4 2019, an estimated $8K.
Capital Bank & Trust first reported a position in Chemed in Q3 2019 and held it in 1 quarter.
Capital Bank & Trust's Chemed position peaked at $8K in Q3 2019.
415 funds tracked by Wall St. Rank held Chemed as of Q4 2019.

Based on Capital Bank & Trust's 13F filing for Q4 2019, filed 18 Feb 2020.